Literature DB >> 19356606

Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.

Maren Lindner1, Jantje Fokuhl, Franziska Linsmeier, Corinna Trebst, Martin Stangel.   

Abstract

The majority of multiple sclerosis lesions fail to remyelinate after chronic demyelinating episodes resulting in neurologic disability. In the current study, chronic demyelination was investigated by using the cuprizone model, a toxic demyelination model. C57BL/6 mice were administered a 0.2% cuprizone diet up to 16 weeks to induce chronic demyelination. For comparison, another group was maintained only for 6 weeks on cuprizone to model acute demyelination. Both groups were analysed regarding the remyelination process after withdrawal of the toxin. Reexpression of myelin proteins after chronic demyelination was reduced by a factor of two as judged by LFB and myelin protein stainings compared to acute demyelination after 2 weeks on remyelination. During chronic demyelination mature oligodendrocytes (Nogo-A positive cells) were severely depleted by 90% compared to age matched controls. Nevertheless, extensive remyelination occurred after withdrawal of cuprizone and was nearly complete after 12 weeks. There was only minimal acute axonal damage as judged by APP staining, with the course of APP positive axons correlating with macrophage/microglia accumulation. Chronic axonal damage detected by SMI-32 positive staining was only seen after chronic demyelination and was still observable during the whole remyelination period. These data suggest that two pattern of axonal injury occur in the cuprizone model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356606     DOI: 10.1016/j.neulet.2009.02.004

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  44 in total

1.  Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features.

Authors:  Mingqiang Xie; Jennifer E Tobin; Matthew D Budde; Chin-I Chen; Kathryn Trinkaus; Anne H Cross; Dennis P McDaniel; Sheng-Kwei Song; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

Review 2.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

3.  Epimedium flavonoids ameliorate neuropathological changes and increases IGF-1 expression in C57BL/6 mice exposed to cuprizone.

Authors:  Mengru Liang; Yongyan Chen; Li Zhang; Lin Li; Guangliang Chen; Linlin Yin
Journal:  Neurochem Res       Date:  2015-02-07       Impact factor: 3.996

4.  Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia.

Authors:  Maria Karamita; Christopher Barnum; Wiebke Möbius; Malú G Tansey; David E Szymkowski; Hans Lassmann; Lesley Probert
Journal:  JCI Insight       Date:  2017-04-20

5.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

6.  Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.

Authors:  T Schmidt; H Awad; A Slowik; C Beyer; M Kipp; T Clarner
Journal:  J Mol Neurosci       Date:  2012-10-05       Impact factor: 3.444

7.  Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice.

Authors:  Nora Hagemeyer; Susann Boretius; Christoph Ott; Axel Von Streitberg; Henrike Welpinghus; Swetlana Sperling; Jens Frahm; Mikael Simons; Pietro Ghezzi; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

8.  An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.

Authors:  Melissa A Partridge; Sumana Gopinath; Simon J Myers; Jens R Coorssen
Journal:  J Chem Biol       Date:  2015-06-12

9.  Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.

Authors:  Miki Furusho; Aude J Roulois; Robin J M Franklin; Rashmi Bansal
Journal:  Glia       Date:  2015-04-22       Impact factor: 7.452

10.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

Authors:  Martine El-Etr; Marion Rame; Celine Boucher; Abdel M Ghoumari; Narender Kumar; Philippe Liere; Antoine Pianos; Michael Schumacher; Regine Sitruk-Ware
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.